Effects of liposteroid on the hemophagocytic syndrome in systemic lupus erythematosus

Abstract

Hemophagocytic syndrome (HPS) is a life-threatening disorder characterized by pancytopenia and activation of macrophages. Recently, corticosteroid incorporated in lipid microspheres (liposteroid) has been reported to be taken up by macrophages and to suppress their functions. Here we present a case of systemic lupus erythematosus complicated by HPS that was successfully treated with liposteroid in addition to an oral corticosteroidand intravenoushigh-dose cyclophosphamidetherapy. The serum levels of tumor necrosis factor-a and ferritin that have been reported to be associated with activity of macrophages remarkably reduced after liposteroid administration. This case suggests that liposteroid is useful for the treatment of HPS.

Keywords

hemophagocytic syndrome liposteroid macrophage pancytopenia

Get full access to this article

View all access options for this article.

References

Wong KF , Hui PK , Chan JK et al. The acute lupus hemophagocytic syndrome . Ann Intern Med 1991; 114: 387-390 .

Mizushima Y , Hamano T , Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion . Ann Rheum Dis 1982; 41: 263-267 .

Yokoyama K , Okamato H , Watanabe M et al. Development of a corticosteroid incorporated in lipid microspheres (liposteroid) . Drugs Exp Clin Res 1985; 11: 611-620 .

Bombardier C , Gladman OD , Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35: 630-640 .

Ramanan AV , Baildam EM. Macrophage activation syndrome is hemophagocytic lymphohistiocytosis-need for the right terminology . J Rheumatol 2002; 29: 1105-1105 .

Lay JD , Tsao CJ , Chen JY et al. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome . J Clin Invest 1997; 100: 1969-1979 .

Emmenegger U , Frey U , Reimers A et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes . Am J Hematol 2001; 68: 4-10 .

Denz H , Huber P , Landmann R et al. Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders . Eur J Haematol 1992; 48: 244-248 .

Suzuki K , Takahashi K , Matsuki Y et al. Fluorescent probe-labeled lipid microsphere uptake by human endothelial cells: a flow cytometric study . Jpn J Pharmac 1992; 60: 349-356 .

10.

Aihara M , Aihara Y , Takahashi Y , Nakajima H. Effects of liposteroid on skin lesions in autoimmune MRLlpr/lpr mice . J Dermatol Sci 1997; 16: 45-51 .